These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19763387)
41. [Living donor liver transplantation for the patient with hepatocellular carcinoma]. Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Maehara Y Gan To Kagaku Ryoho; 2004 Dec; 31(13):2118-21. PubMed ID: 15628755 [TBL] [Abstract][Full Text] [Related]
42. Experience of the transplant team is an important factor for posttransplant survival in patients with hepatocellular carcinoma undergoing living-donor liver transplantation. Majeed TA; Wai CT; Rajekar H; Lee KH; Wong SY; Leong SO; Singh R; Tay KH; Chen J; Tan KC Transplant Proc; 2008 Oct; 40(8):2507-9. PubMed ID: 18929781 [TBL] [Abstract][Full Text] [Related]
44. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria. Jiang L; Liao A; Wen T; Yan L; Li B; Yang J Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007 [TBL] [Abstract][Full Text] [Related]
45. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center. Jonas S; Mittler J; Pascher A; Schumacher G; Theruvath T; Benckert C; Rudolph B; Neuhaus P Liver Transpl; 2007 Jun; 13(6):896-903. PubMed ID: 17538994 [TBL] [Abstract][Full Text] [Related]
46. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma. Kaido T; Ogawa K; Mori A; Fujimoto Y; Ito T; Tomiyama K; Takada Y; Uemoto S Surgery; 2013 Nov; 154(5):1053-60. PubMed ID: 24074704 [TBL] [Abstract][Full Text] [Related]
47. Liver transplantation for HCC: its role: Eastern and Western perspectives. Hwang S; Lee SG; Belghiti J J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):443-8. PubMed ID: 19885638 [TBL] [Abstract][Full Text] [Related]
49. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Hwang S; Lee SG; Joh JW; Suh KS; Kim DG Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545 [TBL] [Abstract][Full Text] [Related]
50. Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma? Chen LP; Li C; Wen TF; Yan LN; Li B; Yang JY Pak J Med Sci; 2015; 31(4):763-9. PubMed ID: 26430399 [TBL] [Abstract][Full Text] [Related]
51. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation. Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029 [TBL] [Abstract][Full Text] [Related]
52. [Value of liver transplantation in hepatocellular carcinoma treatment]. Zheng SS; Wu J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):366-70. PubMed ID: 18795603 [TBL] [Abstract][Full Text] [Related]
53. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma. Yokoi H; Isaji S; Yamagiwa K; Tabata M; Nemoto A; Sakurai H; Usui M; Uemoto S J Hepatobiliary Pancreat Surg; 2006; 13(2):123-30. PubMed ID: 16547673 [TBL] [Abstract][Full Text] [Related]
54. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Ito T; Takada Y; Ueda M; Haga H; Maetani Y; Oike F; Ogawa K; Sakamoto S; Ogura Y; Egawa H; Tanaka K; Uemoto S Liver Transpl; 2007 Dec; 13(12):1637-44. PubMed ID: 18044766 [TBL] [Abstract][Full Text] [Related]
55. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Li C; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Wei YG Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):366-9. PubMed ID: 20688599 [TBL] [Abstract][Full Text] [Related]
56. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912 [TBL] [Abstract][Full Text] [Related]
57. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma. Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632 [TBL] [Abstract][Full Text] [Related]
58. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria. Chua TC; Saxena A; Chu F; Morris DL Am J Clin Oncol; 2012 Apr; 35(2):141-5. PubMed ID: 21336092 [TBL] [Abstract][Full Text] [Related]
59. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria. Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228 [TBL] [Abstract][Full Text] [Related]
60. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Yao FY; Ferrell L; Bass NM; Bacchetti P; Ascher NL; Roberts JP Liver Transpl; 2002 Sep; 8(9):765-74. PubMed ID: 12200775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]